Publications by authors named "Richard Gesser"

Claim this Profile
S
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.
Guy de Bruyn, David L Gordon, Theodore Steiner, Paul Tambyah, Catherine Cosgrove, Richard Gesser

Lancet Infect Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.
Guy de Bruyn, Jamshid Saleh, David Workman, Richard Pollak, Victor Elinoff, Richard Gesser

Vaccine· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A seamless phase IIB/III adaptive outcome trial: design rationale and implementation challenges.
Y H Joshua Chen, Richard Gesser, Alain Luxembourg

Clin Trials· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.
Elmar A Joura, Anna R Giuliano, Ole-Erik Iversen, Celine Bouchard, Constance Mao, Richard Gesser

N Engl J Med· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplexed serologic assay for nine anogenital human papillomavirus types.
David Opalka, Katie Matys, Paul Bojczuk, Tina Green, Richard Gesser

Clin Vaccine Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
Adriano Arguedas, Jaime Cespedes, Francesc Aseni Botet, Jeffrey Blumer, Ram Yogev, Richard Gesser

Int J Antimicrob Agents· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients.
Albert E Yellin, Jeffrey Johnson, Iliana Higareda, Blaise L Congeni, Antonio C Arrieta, Richard Gesser

Am J Surg· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
Joseph Solomkin, Hedy Teppler, Donald R Graham, Richard M Gesser, Anne R Meibohm

J Antimicrob Chemother· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wilbur G Wells, Gail L Woods, Qi Jiang, Richard M Gesser

J Antimicrob Chemother· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of ertapenem.
Hedy Teppler, Richard M Gesser, Ian R Friedland, Gail L Woods, Anne Meibohm

J Antimicrob Chemother· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.
Richard M Gesser, Kathleen A McCarroll, Gail L Woods

Int J Antimicrob Agents· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections.
Richard M Gesser, Kathleen A McCarroll, Gail L Woods

J Infect· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Jose Tellado, Gail L Woods, Richard Gesser, Kathleen McCarroll, Hedy Teppler

Surg Infect (Larchmt)· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.
Hedy Teppler, Kathleen McCarroll, Richard M Gesser, Gail L Woods

Surg Infect (Larchmt)· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
Richard M Gesser, Kathleen McCarroll, Hedy Teppler, Gail L Woods

J Antimicrob Chemother· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.
Ellie J C Goldstein, Diane M Citron, C Vreni Merriam, Yumi Warren, Kerin L Tyrrell, Richard M Gesser

Clin Infect Dis· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
Kevin M Tomera, Emmanuel A Burdmann, Oscar G Pamo Reyna, Qi Jiang, Wendy M Wimmer, Richard M Gesser

Antimicrob Agents Chemother· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.
Fernando Jimenez-Cruz, Abel Jasovich, Jaime Cajigas, Qi Jiang, Danielle Imbeault, Richard M Gesser

Urology· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
Donald R Graham, Christopher Lucasti, Osvaldo Malafaia, Ronald L Nichols, Paul Holtom, Richard Gesser

Clin Infect Dis· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
Barbara A Pelak, Ken Bartizal, Gail L Woods, Richard M Gesser, Mary Motyl

Diagn Microbiol Infect Dis· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis